Suee Lee

3.1k total citations
84 papers, 2.2k citations indexed

About

Suee Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Suee Lee has authored 84 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 20 papers in Surgery. Recurrent topics in Suee Lee's work include Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (14 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Suee Lee is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (14 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Suee Lee collaborates with scholars based in South Korea, United States and Singapore. Suee Lee's co-authors include Sung Yong Oh, Hyojin Kim, Hyuk-Chan Kwon, Sung Hyun Kim, Min Chan Kim, Ji Hyun Lee, Ki Han Kim, Kyung A Kwon, Mee Sook Roh and Hongjo Choi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

Suee Lee

81 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suee Lee South Korea	23	1.3k	787	542	436	349	84	2.2k
Roberto Petrioli Italy	28	1.6k 1.2×	1.2k 1.6×	855 1.6×	407 0.9×	508 1.5×	135	3.1k
Koji Ando Japan	29	1.1k 0.8×	1.1k 1.4×	1.0k 1.9×	287 0.7×	581 1.7×	171	2.5k
George Peros Greece	27	861 0.6×	479 0.6×	790 1.5×	355 0.8×	375 1.1×	76	2.0k
Frank Willeke Germany	32	1.4k 1.1×	1.1k 1.4×	1.1k 2.1×	495 1.1×	453 1.3×	102	3.0k
Koji Murono Japan	26	1.3k 1.0×	552 0.7×	908 1.7×	329 0.8×	339 1.0×	209	2.2k
Feng-Hua Wang China	27	1.4k 1.0×	613 0.8×	696 1.3×	825 1.9×	625 1.8×	56	2.5k
Radka Obermannová Czechia	18	1.4k 1.0×	1.3k 1.7×	1.1k 2.1×	269 0.6×	429 1.2×	60	2.6k
Jan‐Sing Hsieh Taiwan	25	912 0.7×	697 0.9×	740 1.4×	375 0.9×	346 1.0×	79	2.0k
Kazuhiro Sakamoto Japan	26	1.4k 1.0×	1.1k 1.4×	1.2k 2.1×	412 0.9×	466 1.3×	325	3.0k
Jung Yong Hong South Korea	25	1.2k 0.9×	605 0.8×	407 0.8×	353 0.8×	509 1.5×	194	2.3k

Countries citing papers authored by Suee Lee

Since Specialization

Citations

This map shows the geographic impact of Suee Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suee Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suee Lee more than expected).

Fields of papers citing papers by Suee Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suee Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suee Lee. The network helps show where Suee Lee may publish in the future.

Co-authorship network of co-authors of Suee Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Suee Lee. A scholar is included among the top collaborators of Suee Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suee Lee. Suee Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Inkeun, Shinkyo Yoon, Il Hwan Kim, et al.. (2024). Pemetrexed (PEM) maintenance versus observation (OBS) in patients (pts) with advanced urothelial carcinoma (aUC) who completed first-line (1L) platinum-based chemotherapy (CTx) without disease progression (PREMIER, KCSG GU16-05).. Journal of Clinical Oncology. 42(4_suppl). 621–621.

Kim, Hye Ryeon, Jung Hun Kang, Sung Hyun Kim, et al.. (2022). Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors. Cancers. 14(14). 3440–3440. 1 indexed citations

Kim, Ju Won, Soo Hyun Lee, Hye Sook Kim, et al.. (2021). Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13). Cytokine. 142. 155487–155487. 8 indexed citations

Sim, Sung Hoon, In Hae Park, Kyung Hae Jung, et al.. (2019). Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16). British Journal of Cancer. 121(12). 985–990. 7 indexed citations

Oh, Sung Yong, Suee Lee, Jeeyun Lee, et al.. (2018). Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 83(3). 501–508. 7 indexed citations

Park, Yeon Hee, Tae Yong Kim, Young‐Hyuck Im, et al.. (2016). Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results. Cancer Research and Treatment. 49(2). 423–429. 9 indexed citations

Lee, Ho Jin, Dong Hyun Kim, So Yeon Kim, et al.. (2015). Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia. The Korean Journal of Internal Medicine. 30(6). 884–890. 6 indexed citations

Oh, Sung Yong, Won Seog Kim, Jin Seok Kim, et al.. (2015). A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial. Leukemia & lymphoma. 57(6). 1406–1412. 4 indexed citations

Hwang, In Gyu, Jung Hun Kang, Sung Yong Oh, et al.. (2015). Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects. Supportive Care in Cancer. 24(1). 301–309. 9 indexed citations

10.

Oh, Sung Yong, Hyuk-Chan Kwon, Sung Hyun Kim, et al.. (2012). Prognostic Significance of Serum Levels of Vascular Endothelial Growth Factor and Insulin-Like Growth Factor-1 in Advanced Gastric Cancer Patients Treated with FOLFOX Chemotherapy. Chemotherapy. 58(6). 426–434. 9 indexed citations

11.

Lee, Ji Hyun, et al.. (2012). Should we still use Camitta's criteria for severe aplastic anemia?. The Korean Journal of Hematology. 47(2). 126–126. 4 indexed citations

12.

Lee, Suee, Hyuk‐Chan Kwon, Sung-Hyun Kim, et al.. (2012). Identification of genes underlying different methylation profiles in refractory anemia with excess blast and refractory cytopenia with multilineage dysplasia in myelodysplastic syndrome. The Korean Journal of Hematology. 47(3). 186–186. 7 indexed citations

13.

Kwon, Hyuk-Chan, Sung Hyun Kim, Sung Yong Oh, et al.. (2012). Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 17(3). 216–222. 347 indexed citations

14.

Kang, Jung Hun, Jin Pyeong Kim, Ki Mun Kang, et al.. (2011). Treatment Outcomes Between Concurrent Chemoradiotherapy and Combination of Surgery, Radiotherapy, and/or Chemotherapy in Stage III and IV Maxillary Sinus Cancer: Multi-Institutional Retrospective Analysis. Journal of Oral and Maxillofacial Surgery. 70(7). 1717–1723. 43 indexed citations

15.

Chung, Joo Seop, Ho‐Jin Shin, Ho Sup Lee, et al.. (2011). Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma. Cancer Science. 103(3). 477–482. 52 indexed citations

16.

Oh, Sung Yong, Hyuk-Chan Kwon, Suee Lee, et al.. (2010). A Phase II Study of Irinotecan With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFIRI) as First Line Therapy For Patients With Recurrent or Metastatic Gastric Cancer. American Journal of Clinical Oncology. 33(3). 246–250. 16 indexed citations

17.

Kwon, Hyuk‐Chan, Sung Hyun Kim, Sung Yong Oh, et al.. (2010). Clinicopathological significance of nuclear factor‐kappa B, HIF‐1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer. Cancer Science. 101(6). 1557–1561. 28 indexed citations

18.

Lee, Suee, Sung Yong Oh, Hyuk-Chan Kwon, et al.. (2009). Second-Line Treatment With a Combination of Continuous 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Conti-Fam) in Gemcitabine-Pretreated Pancreatic and Biliary Tract Cancer. American Journal of Clinical Oncology. 32(4). 348–352. 51 indexed citations

19.

Kwon, Hyuk-Chan, Sung Yong Oh, Suee Lee, Sunghyun Kim, & Hyojin Kim. (2007). Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study. World Journal of Gastroenterology. 13(46). 6231–6231. 18 indexed citations

20.

Oh, Sung Yong, Hyunah Yoon, Suee Lee, et al.. (2007). Rituximab-induced Interstitial Pneumonitis in a Young Patient: A Case Report and Review of the Literature. The Korean Journal of Hematology. 42(4). 423–423. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact